Some options are. Here’s what’s legal today, what’s limited to research, and how to access legal psychedelic-assisted care in Arizona.
Updated for 2026. General information only — not legal or medical advice.
No pressure. No obligation. Just a conversation about your options.
Same Team only helps you navigate legal, state-authorized psychedelic treatments.
We'll help you understand your options and answer questions.
Complete a short form about your needs and preferences.
We'll help connect you with appropriate providers and next steps.
We help you weigh what matters most so you can find care that fits your life.
Where each treatment stands in Arizona in 2026.
Licensed clinicians can prescribe ketamine, including off-label for depression and other conditions. It is the most widely available legal psychedelic-assisted treatment in Arizona.
FDA-approved for treatment-resistant depression and depression with acute suicidal thoughts. Given only at REMS-certified clinics and usually covered by insurance with prior authorization.
Psilocybin (“magic mushrooms”) is a Schedule I controlled substance and illegal in Arizona. The state funds university clinical trials, and a 2025 law would allow prescribing only if the FDA approves psilocybin and the DEA reschedules it.
Ibogaine is illegal outside research. A 2025 Arizona law (HB 2871) set aside $5 million for clinical trials studying ibogaine for traumatic brain injury and PTSD.
MDMA is not FDA-approved. In 2024 the FDA declined to approve MDMA-assisted therapy for PTSD and requested more research.
Arizona has focused on research rather than consumer access. The state has funded university clinical trials of psilocybin for conditions such as PTSD and depression, and created a Psilocybin Advisory Board.
In 2024, the legislature passed a bill to create licensed psilocybin therapy centers, but the governor vetoed it. In 2025, the governor signed SB 1555, which would allow prescribing pharmaceutical psilocybin only if it is approved by the FDA and rescheduled by the DEA.
Also in 2025, Arizona approved $5 million for clinical trials of ibogaine for traumatic brain injury and PTSD. None of these laws make psilocybin or ibogaine available outside research today.
For most people in Arizona, legal psychedelic-assisted care means ketamine therapy or Spravato from a licensed provider. Spravato is usually covered by insurance; IV ketamine is usually paid out of pocket.
Learn more: Ketamine therapy in Arizona · Is Spravato covered by insurance?
Sources: Arizona Revised Statutes §13-3401; Arizona Legislature, SB 1570 (2024, vetoed), SB 1555 (2025, Laws 2025 Ch. 231), HB 2871 (2025); Laws 2023 Ch. 139 psilocybin research appropriation; FDA complete response letter for MDMA-assisted therapy (August 2024); FDA Spravato prescribing information.
Clear answers to the questions people ask before choosing a clinic.
Partly. Ketamine therapy and Spravato from licensed providers are legal. Psilocybin, ibogaine, and MDMA are not legally available in Arizona outside approved clinical research.
No. Psilocybin is a Schedule I controlled substance under Arizona law, and possession is a felony. No Arizona city has decriminalized it.
Not yet. A 2024 bill to create psilocybin therapy centers was vetoed. A 2025 law (SB 1555) would allow prescribing pharmaceutical psilocybin only if the FDA approves it and the DEA reschedules it. Until then, access is limited to clinical trials.
Ketamine is a dissociative anesthetic. At the doses used for mental health treatment it can cause psychedelic-like changes in perception, which is why ketamine therapy is often grouped with psychedelic therapy.
Possibly. Arizona funds university-based research, and you can search current studies at ClinicalTrials.gov. Eligibility is set by each study.
Ketamine therapy and Spravato. A free Same Team navigation call can help you understand these options, your insurance, and how to connect with a licensed provider.
Schedule a navigation call and a Same Team navigator will help you understand your options and find care that fits.
No pressure. No obligation. Just a conversation.